¼¼°èÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ½ÃÀå : Áúȯ À¯Çüº° ½ÃÀå µ¿Çâ, °³¹ß, µ¿Çâ°ú ¿¹Ãø(Á¦4ÆÇ, 2024-2030³â)
Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
»óǰÄÚµå : 1712819
¸®¼­Ä¡»ç : Kalorama Information
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 285 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,600 £Ü 7,946,000
Online Access (Single User License) help
PDF º¸°í¼­¸¦ 1ºÐÀÌ ¿­¶÷(´Ù¿î·Îµå ºÒ°¡)ÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,352,000
Online Access & PDF Download (Unlimited Users) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

º» º¸°í¼­´Â Çö´ë ÀÇ·á¿¡¼­ ¼¼Æ÷ Ä¡·á ¹× À¯ÀüÀÚ Ä¡·áÀÇ º¯È­ °¡´É¼º¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù. ÀÌ Ä¡·á¹ýÀº Áúº´ÀÇ À¯ÀüÀû ¿øÀο¡ ´ëóÇÏ°í ¸é¿ª°è¸¦ Á¶ÀýÇÔÀ¸·Î½á ȹ±âÀûÀÎ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀ» Ä¡·áºÐ¾ßº°·Î ºÐ·ùÇÏ¿© »ó¼¼ÇÑ ½ÃÀå Ãß°è ¹× ¿¹Ãø, °æÀï ±¸µµ¿¡ °üÇÑ °íÂûÀ» Á¦°øÇÏ´Â Á¾ÇÕÀûÀÎ º¸°í¼­ÀÔ´Ï´Ù.

ÁÖ¿ä Ä¡·á ºÐ¾ß´Â ´ÙÀ½°ú °°½À´Ï´Ù.

  • Á¾¾çÇÐ
  • ½Å°æÇÐ
  • ±Ù°ñ°Ý°è
  • ÇǺΰúÇÐ
  • ¼øÈ¯±â/ºñÁ¾¾ç Ç÷¾×
  • ±âŸ

º» º¸°í¼­¿¡¼­´Â COVID-19ÀÇ RNA ¿ä¹ý°ú °¨¿°Áõ¿ë mRNA ¹é½ÅÀº Á¦¿ÜÇÏ°í ´ë½Å ±¤¹üÀ§ÇÑ À¯ÀüÀÚ Ä¡·áÀÇ Àû¿ë¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

Á¶»ç ¹æ¹ýÀ¸·Î´Â ¾÷°è °ü°èÀÚ¿ÍÀÇ ÀÎÅͺä¿Í Á¾ÇÕÀûÀÎ ¹®Çå Á¶»ç µî 1Â÷ Á¶»ç¿Í 2Â÷ Á¶»ç¸¦ Á¶ÇÕÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®, ¿¹Ãø, °æÀï ºÐ¼®À» Á¦°øÇÏ¸ç ½ÃÀå ÁöÇ¥, µ¿Çâ, À庮¿¡ ´ëÇØ ³íÀÇÇÕ´Ï´Ù. À¯ÀüÀÚ Ä¡·áÀÇ ¿©¸í±âÀ̱⠶§¹®¿¡ ¿¹ÃøÀº ÇÑÁ¤µÈ ¼±Çà »ç·Ê¿¡ ±Ù°ÅÇϰí ÀÖ¾î, 2024³â ½ÃÀå ±Ô¸ð Ãß°è ¹× ¿¹Ãø°ú 2030³â±îÁöÀÇ ¿¹ÃøÀ» Á¦°øÇÕ´Ï´Ù.

º» º¸°í¼­´Â ¼¼Æ÷ Ä¡·á¿Í À¯ÀüÀÚ Ä¡·áÀÇ ÁøÈ­ »óȲÀ» ÀÌÇØÇϱâ À§ÇÑ Áß¿äÇÑ ÀÚ·á·Î¼­ µµ¿òÀÌ µÇ¾î ÇコÄɾî¿Í »ý¸í°øÇÐ ºÐ¾ßÀÇ ÀÌÇØ°ü°èÀÚ¿¡°Ô ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ¼Ò°³

Á¦3Àå Á¾¾çÇп¡¼­ÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ½ÃÀå

Á¦4Àå ½Å°æ °ü·Ã Áúȯ¿¡ÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ½ÃÀå

Á¦5Àå ±Ù°ñ°Ý°è Áúȯ ¹× Àå¾Ö¿¡¼­ÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ½ÃÀå

Á¦6Àå ½ÉÇ÷°ü ¹× Ç÷¾× Áúȯ¿¡¼­ÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ½ÃÀå

Á¦7Àå ÇǺΰú¿¡¼­ÀÇ ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ½ÃÀå

Á¦8Àå ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ½ÃÀåÀÇ »óȲ

Á¦9Àå ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ½ÃÀå ¸®ºä

Á¦10Àå ½ÃÀå ÁøÃâ±â¾÷

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The "Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)" report by Kalorama Information explores the transformative potential of cell and gene therapies in modern medicine. These therapies offer groundbreaking treatments by addressing genetic causes of diseases and modulating the immune system. The report highlights the surge in new therapies and a promising pipeline, with significant clinical trial activity across various therapeutic areas, including oncology and cardiology.

This comprehensive report segments the market by therapeutic areas, providing detailed market estimates, forecasts, and insights into the competitive landscape. It covers global developments in cell, gene, and RNA therapy markets, focusing on key products, research trends, market breakdowns, regional revenues, and competitor analysis.

Key therapeutic areas covered include:

  • Oncology
  • Neurology
  • Musculoskeletal
  • Dermatology
  • Cardiology/Non-oncology blood
  • Other

The report excludes RNA therapies for COVID-19 and mRNA vaccines for infectious diseases, focusing instead on broader gene therapy applications. It also omits cord blood products, considering their classification as transplants.

Methodologically, the report combines primary and secondary research, including interviews with industry participants and comprehensive literature reviews. It provides market highlights, forecasts, and competitive analyses, discussing market indicators, trends, and barriers. Given the nascent stage of gene therapies, forecasts are based on limited precedents, with market size estimates provided for 2024 and projections through 2030.

This report serves as a crucial resource for understanding the evolving landscape of cell and gene therapies, offering valuable insights for stakeholders in the healthcare and biotechnology sectors.

Table of Contents

Chapter 1: Executive Summary

Chapter 2: Introduction to Cell and Gene Therapy

Chapter 3: Cell and Gene Therapy Markets in Oncology

Chapter 4: Cell and Gene Therapy Markets in Neurological-Related Disorders

Chapter 5: Cell and Gene Therapy Markets in Musculoskeletal Conditions and Disorders

Chapter 6: Cell and Gene Therapy Markets in Cardiovascular and Blood Disorders

Chapter 7: Cell and Gene Therapy Markets in Dermatology

Chapter 8: Cell and Gene Therapy Markets in Other Conditions

Chapter 9: Cell and Gene Therapy Market Review

Chapter 10: Market Participants

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â